{
    "2019-01-22": [
        [
            {
                "time": "2018-01-02",
                "original_text": "基金4季报控盘股TOP20:恒华科技、健帆生物超33%",
                "features": {
                    "keywords": [
                        "基金",
                        "4季报",
                        "控盘股",
                        "TOP20",
                        "恒华科技",
                        "健帆生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}